ROMAGNOLI, Romeo
 Distribuzione geografica
Continente #
NA - Nord America 23.092
AS - Asia 9.989
EU - Europa 6.989
SA - Sud America 1.723
AF - Africa 155
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 10
Totale 41.973
Nazione #
US - Stati Uniti d'America 22.731
SG - Singapore 3.825
CN - Cina 3.194
DE - Germania 2.099
BR - Brasile 1.480
UA - Ucraina 1.299
HK - Hong Kong 988
TR - Turchia 910
GB - Regno Unito 753
IT - Italia 660
RU - Federazione Russa 552
VN - Vietnam 511
SE - Svezia 484
FI - Finlandia 423
FR - Francia 218
MX - Messico 175
PL - Polonia 166
CA - Canada 154
IN - India 123
AR - Argentina 96
ID - Indonesia 82
ZA - Sudafrica 72
BD - Bangladesh 68
BE - Belgio 67
JP - Giappone 62
ES - Italia 60
NL - Olanda 54
IQ - Iraq 37
EC - Ecuador 35
AT - Austria 34
CO - Colombia 33
LT - Lituania 31
PK - Pakistan 26
VE - Venezuela 25
EG - Egitto 24
KR - Corea 24
CZ - Repubblica Ceca 22
MA - Marocco 20
UZ - Uzbekistan 20
PY - Paraguay 17
CL - Cile 16
AE - Emirati Arabi Uniti 14
SA - Arabia Saudita 14
TN - Tunisia 12
KE - Kenya 11
NP - Nepal 11
UY - Uruguay 11
EU - Europa 10
AU - Australia 9
IL - Israele 9
TT - Trinidad e Tobago 9
IR - Iran 8
PT - Portogallo 8
AL - Albania 7
AZ - Azerbaigian 7
BG - Bulgaria 7
LV - Lettonia 7
JO - Giordania 6
KG - Kirghizistan 6
KZ - Kazakistan 6
PE - Perù 6
TH - Thailandia 6
DZ - Algeria 5
IE - Irlanda 5
OM - Oman 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
HN - Honduras 4
HR - Croazia 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
ET - Etiopia 3
GA - Gabon 3
GR - Grecia 3
LB - Libano 3
MK - Macedonia 3
PH - Filippine 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
GE - Georgia 2
GP - Guadalupe 2
MD - Moldavia 2
MN - Mongolia 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BZ - Belize 1
CI - Costa d'Avorio 1
Totale 41.951
Città #
Fairfield 2.520
Woodbridge 2.398
Singapore 2.165
Ashburn 2.147
Houston 1.559
Jacksonville 1.385
Chandler 1.308
Ann Arbor 1.234
Dallas 1.088
Beijing 995
Hong Kong 980
Santa Clara 948
Seattle 909
Wilmington 845
Cambridge 762
Izmir 469
Nanjing 434
Princeton 313
Los Angeles 284
Boardman 253
Ferrara 240
Munich 233
San Diego 227
New York 191
Ho Chi Minh City 161
Shanghai 160
Warsaw 148
Shenyang 146
São Paulo 134
Milan 132
Hefei 125
Nanchang 121
Mexico City 116
Bremen 101
Tianjin 99
London 93
Hanoi 91
Changsha 87
Falkenstein 87
Hebei 85
San Mateo 80
Jiaxing 77
Brooklyn 76
Helsinki 76
Turku 75
Chicago 67
Brussels 66
Dong Ket 62
Moscow 56
Jakarta 55
Rio de Janeiro 54
Tokyo 54
Frankfurt am Main 52
Montreal 52
Jinan 51
The Dalles 51
Philadelphia 50
Norwalk 48
Zhengzhou 46
Kunming 45
Toronto 45
Atlanta 44
Falls Church 44
Dearborn 43
Addison 42
Mountain View 42
Phoenix 42
Orem 41
Johannesburg 39
Boston 38
Stockholm 37
Denver 35
Redwood City 35
San Francisco 34
Orange 33
Brasília 32
Guangzhou 32
Chennai 30
Council Bluffs 30
Buffalo 29
Washington 28
Amsterdam 27
Belo Horizonte 27
Indiana 27
Paris 27
Asnières-sur-Seine 26
Des Moines 26
Manchester 24
Ningbo 24
Auburn Hills 23
Nuremberg 23
Poplar 23
Ankara 22
Columbus 22
Curitiba 22
Taizhou 22
Haiphong 21
Tappahannock 20
Mumbai 18
Verona 18
Totale 28.183
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 1.171
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 481
A chemoenzymatic approach to chiral phenylisoserinates using 4-isopropyl-2-oxazolin-5-one as masked umpoled synthon for hydroxycarbonyl anion 257
1-methyl-3-nitro-5-methoxycarbonyl pyrazole 256
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition 238
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 235
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 230
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 229
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 229
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives. 228
A3 adenosine receptor antagonists: History and future perspectives 228
A one-pot synthesis of nitrohydroxylated pyrrolidine and piperidine ring systems by tandem Michael-Henry reaction 223
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 222
A convenient synthesis of unsymmetrically substituted terphenyls of biologically active stilbenes via a double Suzuki cross-coupling protocol 221
Effects of Pimozide Derivatives on pSTAT5 in K562 Cells 220
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 218
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 218
Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity 216
Allosteric modulators for the A1-adenosine receptor 214
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 212
Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders 212
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 208
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 208
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 206
Enantioselective synthesis of (-)-meroquinene through tandem Michael reaction methodology 205
DNA minor groove binders as potential antitumor and antimicrobial agents 205
Allosteric enhancers for A(1) adenosine receptor 204
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 204
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 204
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 203
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin 202
1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors 200
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 197
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 196
2-Arylamino-4-amino-5-aroylthiazoles. "One-pot" synthesis and biological evaluation of a new class of inhibitors of tubulin polymerization 196
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 196
Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines 195
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 195
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 193
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 193
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 192
Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity 192
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 191
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 190
Hybrid molecules based on distamycin A as potential antitumor agents 190
Mastering β-Keto Esters 188
Current status of A1 adenosine receptor allosteric enhancers 188
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 188
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 187
Hybrid molecules between distamycin A and active moieties of antitumor agents 187
Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds 186
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 186
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 185
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 185
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 184
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 184
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 183
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 183
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 182
A new synthetic approach to indazole synthesis 181
Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies 180
A mild one-pot synthesis of thieno[3,4-c]pyrazoles and their conversion into pyrazole analogs of o-quinodimethane 180
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach 180
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 179
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked Heterocycles as template for the adenosine receptor antagonism: Medicinal chemistry approach and sar considerations 179
A new synthetic approach to pyrazolo[3,4-c]-1,2,5-oxadiazoles 178
2-aminothiophene-3-carboxylic acid ester derivatives as novel highly selective cytostatic agents 178
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 176
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 176
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 176
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 175
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 174
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 173
7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A(2A) adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility 173
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 172
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 172
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 170
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 170
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 170
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 170
Synthesis and Biological Evaluation of 1-Methyl-2-(3’,4’,5’-Trimethoxybenzoyl)-3-Amino Indoles as a New Class of Antimitotic Agents and Tubulin Inhibitors 168
Novel combretastatin analogues endowed with antitumor activity 168
Recent developments in the field of adenosine receptor ligands. 166
Recent improvements in the development of A2B adenosine receptor agonists 166
Microwave-assisted synthesis of substituted 2,4-diarylthiazoles and their evaluation as anticancer agents 163
Allosteric Modulators of the A1 Adenosine receptor 163
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 161
A Facile Synthesis of Diaryl Pyrroles Led to the Discovery of Potent Colchicine Site Antimitotic Agents 161
New potent and selective human adenosine A3 receptor antagonists. 161
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells 159
Synthesis and antitumor activity of novel distamycin derivatives 158
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 157
Recent improvements in the development of A2B adenosine receptor agonists 157
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A(3) adenosine receptor antagonists 157
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 156
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 156
Recent developments in the field of A(2A) and A(3) adenosine receptor antagonists 155
Total synthesis of (+/-)-epibatidine 155
New 2-arylpyrazolo[4,3-c]quinoline derivates as potent and selective human A3 adenosine receptor antagonists 155
Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: Synthesis and antitumour activity 154
Totale 20.197
Categoria #
all - tutte 187.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 923
Totale 188.523


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.332 0 0 0 0 0 361 112 472 87 527 459 314
2021/20223.062 116 307 271 154 169 131 143 142 100 238 329 962
2022/20232.979 318 175 74 421 526 456 91 265 388 17 158 90
2023/20241.656 148 197 84 38 110 197 67 360 24 17 43 371
2024/20256.037 119 199 487 240 726 540 165 377 935 683 817 749
2025/20269.646 1.703 979 2.080 2.228 2.421 235 0 0 0 0 0 0
Totale 42.306